𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A sensitive mutation screening strategy for Fabry disease: Detection of nine mutations in the α-galactosidase A gene

✍ Scribed by Lianne C. Blanch; Cathy Meaney; C. Phillip Morris

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
660 KB
Volume
8
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

Fabry disease is an X-linked recessive lysosomal storage disorder caused by a deficiency of a-galactosidase A (a-gal; EC 3.2.1.22). In the past, it has been difficult to give an unequivocal diagnosis of carrier status in Fabry disease because of the overlap between normal and heterozygote enzyme levels. To facilitate rapid and accurate carrier and hemizygote detection, a mutation detection strategy was devised to determine the lesion in our Fabry disease patients. The seven a-gal exons and adjacent intron boundaries from a representative member of each kindred were PCR amplified and analysed for the presence of sequence alterations by single-stranded conformation polymorphism (SSCP) analysis followed by PCR sequencing. Here we report the use of this strategy in the detection and analysis of the causative mutations in 9 patients with classic severe Fabry disease. Three deletions of 1-, 2-, and 3-bp (987delC, 7 17delAA, and AE358), five amino acid substitutions (C52R, G128E, P205T, M284T, and N298K) and a mutation that affects the initiating methionine (MlI) were found in these patients.

Counting a previously reported mutation, this strategy has now successfully detected all the Fabry disease mutations present in the 10 kindreds that have been analysed.

📜 SIMILAR VOLUMES

A novel mutation (E358K) in the α-galact
A novel mutation (E358K) in the α-galactosidase A gene detected in a Japanese family with Fabry disease
✍ Dr. Takashi Miyazaki; Mitsuharu Kajita; Sachiko Ohmori; Naoki Mizutani; Toshimit 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

The enzyme deficiency causes the intralysosomal accumulation of glycosphingolipids. The affected hemizygotes manifest acroparethesis, angiokeratoma, hypohidrosis, corneal opacities, and progressive vascular diseases of the kidney, heart, and brain. The human a-Gal A cDNA (Bishop et al., 1986) and ge

Detection of α-galactosidase a mutations
Detection of α-galactosidase a mutations causing fabry disease by denaturing high performance liquid chromatography
✍ Junaid Shabbeer; Misi Robinson; Robert J. Desnick 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Mutations in the a-galactosidase A (a-Gal A, GLA) gene cause Fabry disease, an X-linked recessive lysosomal storage disease. The majority of mutations are private, and confirmation of carrier status in females requires the definitive identification of a DNA mutation. In addition, knowledge of a fami

Identification of a novel point mutation
Identification of a novel point mutation (S65T) in α-galactosidase A gene in Chinese patients with Fabry disease
✍ Chia-Hsiang Chen; Pei-Wen Shyu; Su-Jen Wu; Song-Shan Sheu; Robert J. Desnick; Kw 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

Fabry disease is an X-linked inborn error of sphingolipid catabolism resulting from deficient enzyme activity of a-galactosidase A. The molecular defects of human a-galactosidase A gene causing Fabry disease have been characterized, including gene rearrangement and point mutations, which show the ge

Fabry disease: Detection of gene rearran
Fabry disease: Detection of gene rearrangements in the human α-Galactosidase A Gene by Multiplex PCR Amplification
✍ Ruth Kornreich; Robert J. Desnick 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

Fabry disease, an X-linked recessive disorder of glycosphingolipid catabolism, results from lesions in the alpha-galactosidase A gene leading to deficient or absent activity of the lysosomal hydrolase. To facilitate the detection of rearrangements in this 14-kb gene, a method was developed for the P